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tratiﬁed squamous epithelia express the 
 
 
 
v
 
 
 
5 integrin,
but in squamous cell carcinomas (SCCs) there is down-
regulation of 
 
 
 
v
 
 
 
5 and up-regulation of 
 
 
 
v
 
 
 
6. To
investigate the signiﬁcance of this ﬁnding, we transduced
an 
 
 
 
v-negative human SCC line with retroviral vectors
encoding 
 
 
 
v integrins. 
 
 
 
v
 
 
 
5-expressing cells underwent
suspension-induced apoptosis (anoikis), whereas 
 
 
 
v-negative
cells and cells expressing 
 
 
 
v
 
 
 
6 did not. Resistance to
anoikis correlated with PKB/Akt activation in suspension,
but not with changes in PTEN or p110
 
 
 
 PI3 kinase levels.
S
 
Anoikis was induced in parental and 
 
 
 
v
 
 
 
6-expressing cells
by inhibiting PI3 kinase. Conversely, activation of Akt or
inhibition of caspases in 
 
 
 
v
 
 
 
5-expressing cells suppressed
anoikis. Caspase inhibition resulted in increased phospho-
Akt, placing caspase activation upstream of decreased Akt
activation. Anoikis required the cytoplasmic domain of 
 
 
 
5
and was independent of the death receptor pathway. These
results suggest that down-regulation of 
 
 
 
v
 
 
 
5 through up-reg-
ulation of 
 
 
 
v
 
 
 
6 may protect SCCs from anoikis by activating
an Akt survival signal.
 
Introduction
 
Extracellular matrix receptors of the integrin family regulate
the growth, differentiation, and tissue assembly of kera-
tinocytes in stratified squamous epithelia such as the epidermis
and the lining of the oral cavity (van der Flier and Sonnenberg,
2001; Watt, 2002). In normal stratified squamous epithelia,
integrin expression is largely confined to the basal, proliferative
layer of cells attached to the underlying basement mem-
brane; expression is lost as cells move through the suprabasal
layers and undergo terminal differentiation. The most abun-
dant integrins in stratified squamous epithelia are 
 
 
 
2
 
 
 
1
(collagen receptor), 
 
 
 
3
 
 
 
1 (laminin receptor), and 
 
 
 
6
 
 
 
4
(laminin receptor; Watt, 2002). Other integrins, such as
 
 
 
v
 
 
 
5 (vitronectin receptor), are expressed at lower levels.
Integrin expression is frequently perturbed in squamous
cell carcinomas (SCCs), which are tumors of stratified squa-
mous epithelia (Mercurio and Rabinovitz, 2001; Watt,
2002). One such change is an up-regulation of 
 
 
 
v
 
 
 
6. In
normal epidermis, 
 
 
 
v forms a heterodimer exclusively with
 
 
 
5 (Pasqualini et al., 1993). In hyperproliferative stratified
squamous epithelia, both 
 
 
 
v
 
 
 
5 and 
 
 
 
v
 
 
 
6 are expressed
(Breuss et al., 1995; Haapasalmi et al., 1996). In SCCs,
 
 
 
v
 
 
 
6 is up-regulated, and this is often correlated with a
down-regulation of 
 
 
 
v
 
 
 
5 expression (Jones et al., 1997;
Regezi et al., 2002). The down-regulation of 
 
 
 
v
 
 
 
5 in associ-
ation with expression of 
 
 
 
v
 
 
 
6 probably reflects a hierarchy
in the preference of 
 
 
 
v to heterodimerize with different 
 
 
 
subunits (Koistinen and Heino, 2002).
There are several ways in which up-regulation of the 
 
 
 
v
 
 
 
6
integrin can affect keratinocyte behavior. 
 
 
 
v
 
 
 
6 binds the
latency-associated peptide derived from latent TGF
 
 
 
 and
activates TGF
 
 
 
 (Munger et al., 1999). Expression of 
 
 
 
v
 
 
 
6
increases epithelial cell motility and invasion (Thomas et al.,
2001b; Ramos et al., 2002), stimulates cell proliferation
(Ahmed et al., 2002), and inhibits fibronectin matrix assembly
(Ramos et al., 2002). The effects on growth and invasion
may reflect the abilities of 
 
 
 
v
 
 
 
6 to activate Erk2 MAPK
(Ahmed et al., 2002) and to up-regulate or activate matrix
metalloproteinases (Agrez et al., 1999; Thomas et al., 2001a;
Ramos et al., 2002).
We have previously described a cell line that provides an
excellent model system for studying the significance of dif-
ferent 
 
 
 
v integrins in SCCs. The H357 cell line is derived
from a human SCC of the tongue and lacks expression of 
 
 
 
v
integrins (Sugiyama et al., 1993). When the 
 
 
 
v subunit is
transfected into H357 cells and 
 
 
 
v-positive clones selected
by multiple rounds of FACS
 
®
 
, 
 
 
 
v is expressed on the cell
surface as 
 
 
 
v
 
 
 
5. Expression of 
 
 
 
v
 
 
 
5 is correlated with inhi-
bition of anchorage-independent growth and induction of
terminal differentiation in H357 cells (Jones et al., 1996). In
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the present experiments, we have uncovered a previously
unrecognized function of 
 
 
 
v
 
 
 
5 in promoting suspension-
induced apoptosis, known as anoikis (Frisch and Francis,
1994), and show that when 
 
 
 
v
 
 
 
5 is replaced at the cell sur-
face with 
 
 
 
v
 
 
 
6, anoikis is prevented. These observations
suggest that up-regulation of 
 
 
 
v
 
 
 
6 may confer a survival ad-
vantage on cells in SCCs.
 
Results
 
Transduction of H357 cells with 
 
 
 
v integrin subunit 
results in surface expression of functional 
 
 
 
v
 
 
 
5
 
In previous experiments, the 
 
 
 
v integrin subunit was intro-
duced into H357 cells by transfection followed by multiple
rounds of FACS
 
®
 
 and clonal selection (Jones et al., 1996).
To avoid such intense selection pressure, we transduced
H357 cells with a retroviral vector encoding 
 
 
 
v (Levy et al.,
1998). As controls, H357 cells were transduced with the
empty retroviral vector or with a vector encoding the 
 
 
 
4 in-
tegrin subunit, which is not expressed in normal stratified
squamous epithelia or SCCs (Watt, 2002).
Cell surface expression of 
 
 
 
v and 
 
 
 
4 was examined by
flow cytometry (Fig. 1). As reported previously (Sugiyama et
al., 1993), parental H357 cells did not express detectable
surface levels of 
 
 
 
v (Fig. 1 a). Transduction with the 
 
 
 
v ret-
roviral vector resulted in higher cell surface levels of the inte-
grin subunit (Fig. 1 b) than achieved previously by transfec-
tion and clonal selection (Fig. 1 c). As expected, parental
cells did not express the 
 
 
 
4
 
 
 
1 integrin (Fig. 1 d). The level
of cell surface expression of the 
 
 
 
4 subunit after retroviral
transduction (Fig. 1, e and f) was the same whether or not
the cells were also transduced with the chick 
 
 
 
1 subunit
(Fig. 1 f), indicating that the endogenous pool of 
 
 
 
1 sub-
units was not limiting. Introduction of the 
 
 
 
v or 
 
 
 
4 integrin
subunits had no effect on cell surface levels of any of the en-
dogenous 
 
 
 
1 integrins (Fig. 1, g–i, and not depicted) nor on
levels of 
 
 
 
6
 
 4 (Fig. 1, j–l).
When H357 cells are transfected with  v and clonally
selected the integrin is expressed as a heterodimer with the
 5 subunit (Jones et al., 1996). To examine heterodimer
formation in H357 cells transduced with the  v retrovi-
rus, cells were labeled with heterodimer-specific antibod-
Figure 1. Expression of  v 5 and  4 1 
integrins in H357 cells. (a–c)  v expression of 
H357 retrovirally infected cells (H357 v) com-
pared with parental cells (H357par) and a clone 
of  v transfected cells, V5, previously described 
by Jones et al. (1996). (d–f) Infection of H357 
cells with  4 alone (H357 4) or in combina-
tion with the chick  1 integrin subunit 
(H357 4 1). (g–l) Comparison of endogenous 
 1 (g–i) or  6 (j–l) integrin expression in 
H357par, H357 v, or H357 4. (m–r) H357par 
and H357 v were labeled with the heterodimer-
specific  v antibodies shown. Gray lines, 
second antibody only; black lines, primary and 
second antibodies. v integrins and anoikis | Janes and Watt 421
ies and analyzed by flow cytometry (Fig. 1, m–r) using
parental H357 cells as negative controls (Fig. 1, m–o).
There was no detectable labeling of  v-transduced cells
with antibodies to  v 3 (Fig. 1 p) or  v 6 (Fig. 1 q).
However,  v 5 was readily detected (Fig. 1 r). We con-
clude that when  v is introduced into H357 cells,
whether by transfection and clonal selection (Jones et al.,
1996) or by retroviral infection (Fig. 1), it is expressed as
the  v 5 heterodimer.
To examine whether or not the  v 5 heterodimer ex-
pressed by retrovirally transduced H357 cells was func-
tional, adhesion assays on vitronectin were performed. Up
to 90% of H357 cells expressing  v 5 adhered to vit-
ronectin, compared with  5% of the parental cells or
H357 cells transduced with the  4 integrin subunit (Fig. 2
a). H357 cells transduced with the  v integrin subunit
spread rapidly on vitronectin, and within 20 min  v 5
was detected in focal adhesions (Fig. 2, b–d).  v 5 did not
localize to focal adhesions in cells plated on fibronectin
(Fig. 2 e). Conversely,  1 integrins localized to focal adhe-
sions when cells were plated on fibronectin (Fig. 2 f) but
not on vitronectin (Fig. 2 g), suggesting that  v 1 het-
erodimers did not form.
 v 5 expression inhibits anchorage-independent 
growth without inducing terminal differentiation of 
H357 cells
Clones of H357 cells transfected with  v were unable to
form colonies in soft agar (Jones et al., 1996). To examine if
retroviral transduction with  v had the same effect on a
polyclonal population, cells were suspended in soft agar for 3
wk, after which time the number of colonies was scored.
Cells transduced with  v showed a marked reduction in col-
ony formation compared with parental cells and cells trans-
duced with the empty vector (Fig. 2 h and Table I).
Figure 2. Effects of  v 5 on cell adhesion, differentiation, and growth in suspension. (a) Adhesion to vitronectin. Diamonds, parental H357 
cells; triangles, H357 cells expressing  4 1; squares, H357 cells expressing  v 5. Data are means and SDs of triplicate samples. (b–g) H357 
cells expressing  v 5 plated on 20  g/ml vitronectin (b–d and g) or fibronectin (e and f) for 30 min, double labeled with phalloidin (red fluorescence) 
and antibodies to  v 5 (b–d),  v (e), or  1 (f and g; green fluorescence). Panel d is the merged image of b and c. Bars, 2  m. (h) Colony formation 
in soft agar. 35-mm dishes of parental H357 (H357par), H357 expressing empty retroviral vector (H357pBp), and cells expressing  v 5 (H357 v). 
(i–p) Flow cytometric analysis of transglutaminase (B.C1) and involucrin (SY5) expression in H357par, H357 v, or H357 4, and normal primary 
keratinocytes. Gray lines, second antibody only; black lines, primary and secondary antibodies.
Table I. Percentage of colony-forming efficiency (CFE) of H357 
cells in soft agar
Percentage
of CFE
H357 parental H357 expressing
empty vector
H357 expressing
 v 5
Experiment 1 25.4   3.0 20.3   2.2 0.2   0.1
Experiment 2 18.7   1.2 16.2   1.4 0.1   0.1
Experiment 3 25.2   2.8 24.6   1.6 0.0   0.1
Three separate experiments are shown. Data are means and SDs of
triplicate dishes.422 The Journal of Cell Biology | Volume 166, Number 3, 2004
In clones of H357 cells transfected with  v, suppression
of anchorage-independent growth correlates with an in-
creased ability to undergo terminal differentiation, as mea-
sured by expression of involucrin (Jones et al., 1996). Ter-
minal differentiation of retrovirally transduced H357 cells
was examined by Western blotting, immunofluorescence
microscopy, and flow cytometry with antibodies to involu-
crin and two additional markers of terminal differentiation,
transglutaminase 1 and cornifin (Fig. 2 and not depicted).
Neither transduction with  v nor with  4 increased the
proportion of terminally differentiated cells (Fig. 2, i–k
and m–o). As reported previously (Jones et al., 1996), H357
cells had a much lower proportion of differentiated cells
( 0.5%) than primary human keratinocytes (Fig. 2, l and
p). Whereas suspension induces terminal differentiation of
primary keratinocytes, this was not the case for H357 cells,
irrespective of whether or not they expressed  v (Jones et al.,
1996; unpublished data).
 v 5 induces anoikis of H357 cells
Next, we investigated whether or not expression of  v 5 in-
duced anoikis (Frisch and Francis, 1994). We determined
the proportion of cells with a sub-G1 DNA content, as a
measure of the number of apoptotic cells (Frisch, 1999b).
We compared parental H357 cells, cells transduced with the
empty retroviral vector, cells transduced with  v, and cells
transduced with  4.
Typical flow cytometry profiles are shown in Fig. 3 a, and
data pooled from six experiments are shown in Fig. 3 b. The
proportion of cells with a sub-G1 DNA content was  3%
in freshly harvested cells. In parental cells and cells trans-
duced with  4 or empty vector, the proportion increased to
almost 10% by 48 h and 20% by 72 h in suspension. Cells
transduced with  v had a similar level of apoptosis to con-
trols after 24 h in suspension, but by 48 h the proportion of
apoptotic cells had increased to almost 30%, and to over
50% by 72 h. The increased apoptosis of H357 cells trans-
duced with  v compared with controls was statistically sig-
nificant (P   0.008 at 72 h; t test).
The results were confirmed using two other methods to
quantitate apoptosis, TUNEL (unpublished data) and mi-
croscopic evaluation of nuclear morphology in cells labeled
with Hoechst 33258. The percentage of cells with con-
densed, fragmented nuclei and the SEM of three separate ex-
periments (each counting 200 cells) were as follows. At time
0, 1.7   0.1% of H357 cells expressing  4 were apoptotic,
and this increased to 14.6   1.7% after 72 h in suspension.
At time 0, 1.5   0.1% H357 cells expressing  v were apop-
totic, a level that was similar to cells expressing  4. How-
ever, after 72 h in suspension this level had risen to 64.2  
3.2%, fourfold higher than in  4-expressing cells.
Anoikis is inhibited by integrin ligation of suspended cells
or by treatment with caspase inhibitors (Frisch, 1999b).
Therefore, we examined the effects of these treatments on
H357 cells expressing  v 5 (Fig. 3 c). The cells were held in
suspension for 48 or 72 h in medium alone (control) or con-
taining DMSO (caspase inhibitor solvent), the pan caspase
inhibitor z-VAD–fmk (100  M), vitronectin (100  g/ml;
 v ligand), or the  v function-blocking antibody 13C2
(100  g/ml; Davies et al., 1989). At both time points,
z-VAD-fmk and vitronectin substantially reduced the pro-
portion of apoptotic cells. 13C2 also had an inhibitory ef-
fect, albeit slightly smaller.
We conclude that unligated  v 5 expression in H357
cells leads to an increase in suspension-induced apoptosis
and that this is the likely mechanism by which anchorage-
independent growth is inhibited.
Effect of overexpressing  v in cells with normal 
endogenous levels of  v 5
To investigate whether or not  v 5-induced anoikis was
specific to H357 cells or a more general phenomenon, we
transduced a second SCC line, SCC4, and primary human
keratinocytes with the  v or  4 retroviral vectors (Fig. 3, d–g).
SCC4 has a similar level of endogenous  v integrins to
primary keratinocytes (Fig. 3, d and f; Levy et al., 2000), but
is heterozygous for an activating  1 integrin mutation
(Evans et al., 2003). The levels of  v expression achieved by
retroviral transduction were higher than the endogenous lev-
els (Fig. 3, d and f) and equivalent to that of  v-transduced
H357 cells (Fig. 1 b).
Fig. 3 h shows pooled data from three experiments in
which the proportion of apoptotic SCC4 cells was compared
immediately after detachment from the culture dish (0 h) or
after suspension for 24 or 48 h. At both 24 and 48 h, the
proportion of apoptotic cells was significantly higher in cells
transduced with  v than in parental SCC4 or SCC4 trans-
duced with the  4 retroviral vector (P   0.05).
It has previously been reported that when primary human
keratinocytes are placed in suspension they undergo termi-
nal differentiation as opposed to anoikis (Gandarillas et al.,
1999). Consistent with those observations, the proportion
of primary keratinocytes in suspension with a sub-G1 DNA
content did not exceed 15%, even after 48 h (Fig. 3 i). The
proportion of apoptotic cells was not significantly different
when parental keratinocytes were compared with kerati-
nocytes transduced with  4 or  v retroviral vectors (Fig. 3
i). The proportion of cells that underwent terminal differen-
tiation was also unaffected by overexpression of  v or  4
(unpublished data).
We conclude that in the SCC lines examined elevated ex-
pression of  v stimulated anoikis independent of whether or
not the parental cells expressed  v. However, overexpression
of  v in primary keratinocytes was not sufficient to induce
anoikis.
Role of PI3 kinase activation in anoikis
Signaling pathways known to protect cells from anoikis in-
clude FAK activation leading to Erk MAPK phosphorylation
and PI3 kinase activation resulting in activation of PKB/Akt
(Frisch et al., 1996). There is conflicting evidence regarding
c-Jun kinase and p38 MAPK (Frisch et al., 1996; Khwaja and
Downward, 1997). To examine the role of these pathways
in anoikis of H357 cells, we added the PI3 kinase inhibi-
tor LY294002, the MEK1/2 inhibitor UO126, and the
p38MAPK inhibitor SB203580 to H357 cells transduced
with  v or  4 and measured the proportion of apoptotic cells
after 72 h in suspension (Fig. 4 a). z-VAD-fmk was added as v integrins and anoikis | Janes and Watt 423
Figure 3. Expression of  v 5 in SCC cells induces anoikis. (a) DNA content of H357 cells (parental or transduced with  v or  4) after 0, 24, 48, 
or 72 h in suspension. Regions corresponding to sub-G1, G1, S, and G2 M are indicated. (b) Percentage of anoikis was determined as the 
percentage of cells with sub-G1 DNA content. SEM of six experiments are shown, comparing parental H357 cells to those expressing empty 
vector (pBabe puro),  4, or  v. (c) H357 cells transduced with  v suspended in medium alone (Cont) or supplemented DMSO, z-VAD-fmk 
(CI) at 100  M, 100  g/ml vitronectin (VN), or 100  g/ml 13C2 anti- v. Means and SDs of three experiments are shown. (d–g) Flow cytometry 
profiles of SCC4 and primary human keratinocytes (strain km) labeled with secondary antibody alone (dashed lines) or antibodies to  v or  4 
integrins. Gray lines, parental cells; black lines, cells transduced with  v (d and f) or  4 (e and g). (h and i) Percentage of anoikis (sub-G1 DNA) 
of parental SCC4 cells and primary keratinocytes (km) or cells transduced with  v or  4 integrin subunits. SEM of three experiments are shown.424 The Journal of Cell Biology | Volume 166, Number 3, 2004
a positive control to block anoikis (Fig. 4 a). None of the in-
hibitors tested had any effect on the proportion of  v 5-
expressing cells that underwent apoptosis. However, the PI3
kinase inhibitor increased apoptosis of  4-expressing cells to
the level of cells expressing  v 5 (Fig. 4 a).
Activation of PI3 kinase leads to recruitment of Akt to the
plasma membrane, where it is activated by phosphorylation
on threonine 308 and serine 473 (Toker and Newton,
2000). To test if parental H357 cells in suspension had an
active PKB/Akt signaling pathway that was overcome by ex-
pression of  v 5, Western blots of proteins from suspended
cells were probed with an antibody to the serine 473–phos-
phorylated (and hence activated) form of Akt (Fig. 4 b). In
parental H357 cells, cells transduced with pBabe puro, or
cells transduced with  4, activation of Akt was detected
within 24 h of suspension and became maximal at 72 h (Fig.
4 b and not depicted). However, in cells expressing  v 5,
Akt phosphorylation was not detected (Fig. 4 b). Treatment
of  4-expressing cells with the PI3 kinase inhibitor that in-
duced them to undergo anoikis (Fig. 4 a) blocked Akt acti-
vation (Fig. 4 b).
The proapoptotic effect of  v 5 is not shared with 
 v 6 and is mediated by the  5 cytoplasmic domain
Because up-regulation of  v 6 is a feature of many SCCs,
we investigated whether or not this integrin, like  v 5, pro-
moted anoikis. H357 cells transduced with the  v retroviral
vector were infected with a second vector that encoded the
 6 integrin subunit. Introduction of  6 had no effect on
cell surface levels of  v (Fig. 5 a; compare Fig. 1 b). How-
ever, cells no longer expressed surface  v 5 (detected with
P1F6 antibody); instead all of the  v on the cell surface was
now in a heterodimer with the  6 subunit (detected with
10D5 antibody; Fig. 5 a).
The relative levels of integrins in H357 cells were also
compared by Western blotting (Fig. 5, c–e). As expected,
there was no difference in  1 integrin levels between paren-
tal H357 cells and cells expressing  v 5 or  v 6 (Fig. 5 c).
The  v subunit was not detected in parental cells and was
expressed at similar levels in cells transduced with  v ( v 5-
expressing cells) or with  v and  6 (Fig. 5 c). There was no
detectable  6 protein in parental H357 cells;  6 was weakly
detectable in cells transduced with  v alone and was strongly
expressed in cells transduced with both  v and  6 (Fig. 5 d).
 5 protein was detectable in all three cell populations, but
was more abundant in cells transduced with  v than paren-
tal cells or cells transduced with  v and  6 (Fig. 5 e). The
 5 protein band in Western blots of parental and  v 6 cells
was less diffuse and migrated slightly faster than in cells
transduced with  v, which is consistent with intracellular
accumulation and incomplete glycosylation (Fig. 5 e).
In contrast to cells expressing  v 5, cells expressing  v 6
did not undergo anoikis and had the same sub-G1 DNA
profiles as parental H357 cells (Fig. 5 f) and cells transduced
with the  4 integrin subunit (Fig. 5 g). Whereas cells ex-
pressing  v 5 did not activate Akt in suspension, cells ex-
pressing  v 6 did activate Akt (Fig. 5 h) and the kinetics
were similar to parental cells and cells expressing  4 (Fig. 4
b and not depicted). Akt activation in  v 6-expressing cells
was blocked by treatment with the PI3 kinase inhibitor
LY294002 (Fig. 5 h).
To investigate whether or not the cytoplasmic domain of
the   5 subunit conferred sensitivity to anoikis, we con-
structed a chimeric integrin subunit, consisting of the  6 ex-
tracellular and transmembrane domains and the  5 cyto-
plasmic domain ( X6C5). H357 cells were doubly infected
with  v and  X6C5 retroviral vectors, and cells were exam-
ined by flow cytometry with an  v 6-specific antibody (Fig.
5 b). Cells transduced with  X6C5 alone did not express the
chimera on the cell surface, confirming that it only het-
erodimerized with  v (unpublished data).
Cells were placed in suspension for 72 h, and the propor-
tion of apoptotic cells was compared in parental H357 cells
and cells expressing  v 5,  v 6, or  v X6C5. The results
of one experiment are shown in Fig. 5 f, and data pooled
from three separate experiments are shown in Fig. 5 g. H357
cells expressing  v X6C5 were as susceptible to anoikis as
cells expressing  v 5. We conclude that the cytoplasmic do-
main of  5 mediates the proapoptotic effect of  v 5.
The ability of H357 cells to avoid anoikis again correlated
with their ability to activate Akt in suspension (Fig. 5 i). Pa-
rental cells and cells expressing  v 6 activated Akt, whereas
cells transduced with  v (expressed on the cell surface as
 v 5) or  v X6C5 did not.
Activation of Akt can overcome the proapoptotic 
effect of  v 5
If  v 5 expression triggers anoikis by preventing activation of
Akt, then constitutive activation of Akt should allow  v 5-
Figure 4. Protection from anoikis correlates with Akt activation. 
(a) Anoikis of H357 cells transduced with  v or  4 integrin after 72 h 
in suspension. cont, medium alone; DMSO, solvent control; CI, 100 
 M z-VAD-fmk; PI3KI, 50  M LY294002; MEKI, 10  M UO126; 
p38MAPKI, 10  M SB203580. Data are SEM of three experiments. 
(b) Western blot of H357 cells expressing  4 or  v held in suspen-
sion for the number of hours shown. (right hand lane) H357 4 
suspended in the presence of LY 294002 for 72 h. Blot was probed 
with an antibody to phosphoAkt 
473 or actin (loading control). v integrins and anoikis | Janes and Watt 425
expressing cells to survive in suspension. Two Akt con-
structs were introduced into H357 cells. The first construct,
M Akt:ER*, has a myristoylation targeting sequence fused to
the NH2 terminus of a constitutively active form of Akt lack-
ing the PH domain (myrAkt del4-129). At the COOH termi-
nus is a modified form of the hormone-binding domain of the
mouse estrogen receptor (ER) that binds 4-hydroxytamoxifen
(OHT) but is refractory to estrogen. In response to OHT,
M Akt:ER* is rapidly recruited to the plasma membrane
where it is activated by local PI3 kinases. The second con-
Figure 5. The proapoptotic effects of  v 5 are mediated by the  5 cytoplasmic domain. (a and b) Flow cytometry of H357 cells expressing 
 v 6 (a) or  v X6C5 (b), using antibodies specific for the  v heterodimers indicated. (c–e) Western blots of parental H357 cells (par), H357 cells 
transduced with  v alone ( v 5) or  v and  6 ( v 6) probed with antibodies to the integrin subunits shown. Loading controls were actin or Erk 
MAPK. (f) DNA content of cells suspended for the times indicated. Shown are H357par and cells transduced with  v,  v 6, or  v X6C5. 
(g) SEM of percentage of anoikis in three separate experiments. (h and i) Western blot probed with antibodies to phosphoAkt
473, total Akt, or 
actin. (h) Cells were suspended for the times shown. (right hand lane) Cells suspended with Ly294002 (50  M). (i) Cells suspended for 72 h.426 The Journal of Cell Biology | Volume 166, Number 3, 2004
struct, A2M Akt:ER*, acts as an inactive control because the
myristoylated glycine at the second amino acid position has
been converted to alanine to eliminate the membrane-tar-
geting function (Kohn et al., 1998). M Akt:ER* and A2M 
Akt:ER* were expressed in retroviral vectors and intro-
duced into parental and  v-expressing H357 cells. Adherent
cultures were treated with OHT for 1 h, lysed, and examined
by Western blotting. An antibody to the mutant ER detected
expression of the Akt constructs at equal levels in all cell popu-
lations (Fig. 6 a). The level of endogenous serine 473–phos-
phorylated Akt was also the same in all cells (Fig. 6 a). How-
ever, only cells expressing M Akt:ER* had a second band
detected by anti-phosphoAkt, which migrated at 97 kD, the
size of the AktER fusion protein (Fig. 6 a). H357 parental
cells and cells expressing  v or  4 were transduced with the
active or inactive Akt constructs and placed in suspension for
72 h in the presence of OHT (Fig. 6, b and c). Parental H357
cells and  4-expressing cells had a low level of anoikis that was
not influenced by Akt activation. H357 cells expressing  v 5
and the inactive Akt construct underwent anoikis, and the
proportion of apoptotic cells was equivalent to that seen in
cells expressing  v 5 alone (Fig. 6 c). H357 cells expressing
active Akt were protected from anoikis and had the same low
level of apoptotic cells as H357 parental cells and cells express-
ing  4 (Fig. 6, b and c). The conclusions from the flow cy-
tometry experiments were confirmed by evaluating nuclear
morphology of cells stained with Hoechst 33258 (unpub-
lished data). The level of serine 473–phosphorylated Akt
was compared in  v-expressing H357 cells transduced with
M Akt:ER* or A2Akt:ER* after 72 h in suspension (Fig. 6
d). Cells expressing the inactive construct had no activation of
AktER and either low or no phosphorylation of endogenous
Akt. In contrast, both the myristoylated construct and endog-
enous Akt were activated in cells expressing M Akt:ER*.
 v 5-induced anoikis of H357 cells is not mediated by 
activation of the death receptor pathway
Apoptosis can be triggered by intrinsic or extrinsic path-
ways. The intrinsic pathway involves alterations in mito-
chondrial homeostasis and activation of the apoptosome;
Figure 6. Akt activation protects against anoikis. (a) Western blot of adherent H357 cells transduced with M
 Akt:ER* or A2Akt:ER* alone 
(parMyr and parA2, respectively) or in combination with  v integrin ( vMyr and  vA2, respectively) and treated with OHT (1  M) for 1 h. 
(top) The antibody to phospho-Akt detects endogenous phospho-Akt in all cells (bottom band), and phosphorylated M
 Akt:ER in cells 
expressing that construct. (bottom) Probed with anti-ER. (b and c) Anoikis of H357 cells transduced with M
 Akt:ER* (Myr) or A2Akt:ER* (A2) 
alone (parent) or in combination with  v or  4 integrins. Cells were suspended for 72 h in the presence of OHT. (c) SEM of three experiments. 
(d) Western blot of H357 vMyr or  vA2 suspended for 72 h with 0.1  M OHT, probed with anti-phosphoAkt
473 (top), total Akt (middle), and 
ER (bottom). (top panel) Anti-phosphoAkt recognizes two bands, corresponding to endogenous Akt (bottom band) and to phosphorylated 
M
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the extrinsic pathway occurs through ligand binding of
death domain surface receptors such as Fas (Grossmann,
2002). Experiments on MDCK cells, derived from a simple
epithelium, have shown that anoikis is induced by the ex-
trinsic pathway, involving death receptors and their associ-
ated adaptor molecules (Frisch, 1999a; Rytömaa et al.,
1999). MDCK cell anoikis can be blocked by a dominant-
negative (dn) FADD (FAS associated death domain pro-
tein) mutant (dNFADD), which cannot activate caspase 8.
Caspase 8 can also be stimulated by a mitochondrially
driven feedback mechanism (intrinsic pathway) involving
caspase 9 (Rytömaa et al., 1999).
Suspension experiments were performed in the presence
of the general caspase inhibitor z-VAD-fmk (Fig. 4 a and
Fig. 7 a), the caspase 8 specific inhibitor z-IETD-fmk, and
the caspase 9 inhibitor z-LEHD-fmk (Fig. 7 a). All three
drugs inhibited apoptosis of  v 5-expressing cells to the
same extent (Fig. 7, a and b). This finding suggested that the
intrinsic pathway was involved in anoikis.
To determine whether or not anoikis was indeed death re-
ceptor independent, we introduced dnFADD into  v-ex-
pressing H357 cells. The dnFADD construct, tagged with
eGFP, was subcloned into pBabe puro and used to infect
H357 cells. A high level of expression of dnFADD in over
90% of cells was achieved (Fig. 7 c). Suspension experiments
were performed comparing parental H357 cells, H357 cells
expressing  v alone, and H357 cells expressing both  v and
dnFADD. Expression of dnFADD had no effect on anoikis
of  v-expressing H357 cells (Fig. 7 d). As a positive control,
dnFADD was also introduced into MDCK cells; it inhibited
anoikis even more effectively than z-VAD-fmk (Fig. 7 e).
This finding suggests that FADD does not play a role in
 v 5-mediated anoikis.
Inhibition of caspase 8 increases Akt activity
We investigated potential mechanisms by which Akt phos-
phorylation was down-regulated when  v 5-expressing H357
cells were held in suspension for 72 h. PTEN is a negative reg-
Figure 7.  v 5-mediated anoikis is 
independent of FADD. (a and b) Anoikis 
of  v-transduced H357 cells suspended 
in presence of caspase inhibitors z-IETD-
fmk (caspase 8), z-LEHD-fmk (caspase 
9), and z-VAD-fmk (pan caspase). (b) 
SEM of three experiments. (c) Flow cyto-
metric profiles of  v-expressing H357 
cells before and after transduction with 
eGFP-dNFADD-AU1. GFP fluorescence 
is shown. (d) SEM of two experiments 
comparing the percentage of anoikis 
after 0 or 72 h in suspension. Parental 
H357 cells were compared with cells 
transduced with  v (H357 v) alone or in 
combination with dnFADD. (e) Effect of 
z-VAD-fmk (CI) and dnFADD on MDCK 
anoikis was measured by flow cytometry 
of annexin V–positive cells. Data are 
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ulator of Akt-dependent cell survival (Stambolic et al., 1998);
however, there was no difference in PTEN levels in parental
cells or cells expressing  v 5 or  v 6 (Fig. 8 a). In addition,
there was no difference in expression of PI3 kinase, as judged
by the level of the p110  subunit detected on Western blots
(Fig. 8 b), nor in the total level of Akt (Fig. 8 c).
To investigate the relationship between caspases and Akt
phosphorylation,  v 5-expressing cells were suspended for
72 h in the presence or absence of caspase inhibitors. The
pan caspase inhibitor z-VAD-fmk and the caspase 8 inhibi-
tor z-IETD-fmk increased the level of phosphoAkt, whereas
the caspase 9 inhibitor z-LEHD-fmk did not (Fig. 8 c). We
conclude that caspase 8 is upstream of Akt in  v 5-medi-
ated anoikis.
Discussion
When the  v integrin subunit was introduced into  v-nega-
tive H357 cells it formed a functional heterodimer on the
cell surface with the  5 subunit. Expression of  v 5 in-
duced anoikis, which could be blocked by integrin ligation
or caspase inhibition but not by blocking FADD death re-
ceptor signaling. The effect was not specific for H357 cells
because a second SCC line was also stimulated to undergo
anoikis by overexpression of  v. Anoikis was dependent on
the  5 cytoplasmic domain and was not observed in cells ex-
pressing  v 6. Anoikis of parental H357 cells was induced
with a PI3 kinase inhibitor and correlated with a failure of
 v 5-expressing cells to activate Akt in suspension. Resis-
tance to anoikis was achieved by constitutive activation of
Akt or caspase inhibition. Caspase 8 inhibition resulted in
increased phosphoAkt levels, placing caspase 8 upstream of
Akt. We conclude that  v 5 confers susceptibility to
anoikis in SCC cells and that this is overridden when  5 is
removed from the cell surface through loss of  v or up-regu-
lation of the  6 integrin subunit. Up-regulation of  6 is a
common feature of human SCCs, and we propose that this
is a means of allowing growth of tumor cells in the absence
of a basement membrane. This is a novel way in which up-
regulation of  v 6 contributes to cancer progression.
The ability of integrin ligation to suppress apoptosis is
well established, and several different mechanisms have been
reported, reflecting a degree of cell type and integrin speci-
ficity (for review see Jost et al., 2001; Miranti and Brugge,
2002). Ligation of integrins can induce antiapoptotic pro-
teins, such as Bcl-2 (Matter and Ruoslahti, 2001), or sup-
press proapoptotic proteins, such as Bax (Gilmore et al.,
2000; Valentijn et al., 2003). Ligation of  5 1 or  v 3 in-
creases Bcl-2 expression through NF B activation (Scatena
et al., 1998). Integrin activation of FAK leads to increased
expression of inhibitors of apoptosis proteins, which bind to
and inhibit executioner caspases (Sonoda et al., 2000).
Previous work on anoikis has demonstrated the involve-
ment of death receptor signaling and the subsequent activa-
tion of the extrinsic death pathway via caspase 8 activation
(Frisch, 1999a; Rytömaa et al., 2000).  v 5-mediated
anoikis could not be inhibited with dnFADD, suggesting
that unlike anoikis of endothelial cells and simple epithelial
cells (Frisch, 1999a; Rytömaa et al., 1999; Hood et al.,
2003), SCC anoikis is independent of death receptor sig-
naling. In endothelial cells,  v 5 ligation protects against
FADD-mediated apoptosis (Hood et al., 2003), demon-
strating that the same integrin can regulate apoptosis by dis-
tinct mechanisms, dependent on cellular context.  v 5-
mediated anoikis could be blocked with inhibitors of caspase
8 and 9. Caspase 8 can be activated independently of the ex-
trinsic death pathway in cells with unligated integrins (Stu-
pack et al., 2001). Caspase 8 cleaves Bid (a Bcl-2 family
member), triggering mitochondrial cytochrome c release and
activation of caspase 9 (Rytömaa et al., 2000). Caspase 9
may then lead to further cleavage and activation of caspase
8, hence amplifying the signal (Rytömaa et al., 2000).
It has previously been reported that whereas unligated  1
and  3 integrin subunits can directly activate caspase 8,  5
does not (Stupack et al., 2001). In agreement with this re-
port, we were unable to coimmunoprecipitate  v 5 or  v 6
with caspase 8 in H357 cells under a variety of conditions
(unpublished data). In H357 cells expressing  v 5 it is more
likely that the  5 cytoplasmic tail activates caspase 8 indi-
rectly via effects on the cytoskeleton. In some dying cells, ac-
tin, integrins, and caspase 8 have been seen to colocalize in
complexes that lack death receptors and FADD (Stupack et
al., 2001), and local accumulation of caspase 8 is sufficient to
trigger apoptosis. The mechanism of the association of cas-
pase 8 with the cytoskeleton is not known, but newly de-
scribed proteins Hip and Hippi, homologous to cytoskeleton
linker proteins talin and myosin, have been found that in-
clude “pseudo-death effector domains” (Gervais et al., 2002).
In contrast to  v-negative H357 cells and cells expressing
 v 6, cells that expressed  v 5 did not activate Akt in sus-
pension. The pro-survival function of Akt is well established.
Activated Akt can phosphorylate and inhibit several different
proapoptotic proteins including BAD (Datta et al., 1997)
and caspase 9 (Cardone et al., 1998). Active Akt also induces
NF B (Kane et al., 1999), which reduces the release of cyto-
Figure 8. Mechanisms by which Akt phosphorylation could be 
regulated. (a and b) Western blots of parental H357 cells (par) or 
cells transduced with  v alone or  v and  6 were suspended for 72 h 
and probed with antibodies to PTEN (a) or PI3 kinase (p110  subunit; 
b). Actin (a) and Erk MAPK (b) were loading controls. (c) Western 
blots of H357 cells transduced with  v probed with anti-phosphoAkt
473 
and total Akt. Cells were suspended for 72 h with 100  M z-VAD-
fmk, z-IETD-fmk, z-LEHD-fmk, or DMSO. Amount of protein loaded 
per track was greater than sixfold higher than in blots shown in 
Figs. 4–6. v integrins and anoikis | Janes and Watt 429
chrome c from mitochondria (Kennedy et al., 1999). Akt is
negatively regulated by the phosphatase PTEN, and a lack of
PTEN leads to increased resistance to apoptosis (Lu et al.,
1999). However, there were no differences in PTEN levels in
parental H357 cells or cells expressing  v 5 or  v 6.
The mechanism by which unligated  v 5 triggers
anoikis requires activation of caspases 8 and 9 and suppres-
sion of Akt activity. Because there was no reduction in to-
tal Akt when  v 5-expressing H357 cells were held in sus-
pension, caspase-dependent cleavage of Akt (Bachelder et
al., 2001) does not appear to be involved. Nevertheless, in-
hibition of caspase 8 did lead to an increase in phospho-
Akt, placing caspase 8 upstream of the suppression of Akt
activation. Inhibition of caspase 9 did not increase phos-
phoAkt, leading us to speculate that Akt is upstream of cas-
pase 9 (Cardone et al., 1998).
One striking difference between primary human kerati-
nocytes and SCC cells is that primary keratinocytes undergo
terminal differentiation and not anoikis when held in suspen-
sion (Gandarillas et al., 1999). Moreover, when unligated in-
tegrins are expressed in the suprabasal layers of the epidermis,
apoptosis is not stimulated (Carroll et al., 1995). When  v
was overexpressed in primary human keratinocytes they re-
tained the ability to terminally differentiate and did not un-
dergo anoikis. It seems possible that the selection pressure
placed on clones of  v-transfected H357 cells described pre-
viously selected for rare cells that had the ability to terminally
differentiate rather than apoptose (Jones et al., 1996).
The similarities between apoptosis and keratinocyte ter-
minal differentiation have previously been discussed and in-
clude inhibition of suspension-induced differentiation by in-
tegrin ligation (Levy et al., 2000) and by caspase inhibitors
(Allombert-Blaise et al., 2003). Akt activation plays a role in
driving the later stages of keratinocyte terminal differentia-
tion (Janes et al., 2004). We speculate that by preventing
Akt activation,  v 5 acts as a fail-safe device, triggering
anoikis in SCC cells that have lost the ability to differentiate.
Resistance to anoikis can potentially enhance epithelial neo-
plasia by allowing cells to proliferate in the absence of at-
tachment to extracellular matrix and to leave their normal
environment and travel to distant body sites, thereby form-
ing metastases. Up-regulation of  v 6 is a novel mechanism
by which tumor cells can avoid anoikis.
Materials and methods
Cell culture
Human epidermal keratinocytes (strain km, passage 2–6) were cultured on
a feeder layer of J2 3T3 cells in FAD medium (1 part Ham’s F12, 3 parts
DME, and 180  M adenine) supplemented with 10% FCS and HICE cock-
tail (0.5  g/ml hydrocortisone, 5  g/ml insulin, 10
 10 M cholera entero-
toxin, and 10 ng/ml EGF), essentially as described previously (Levy et al.,
1998). The H357 (Sugiyama et al., 1993; a gift from S. Prime, University of
Bristol, Bristol, UK) and SCC4 (Evans et al., 2003) cell lines were cultured
in FAD, 10% FCS, and HICE without a feeder layer. J2-3T3 cells and puro-
mycin-resistant J2-3T3 cells (J2-puro; Levy et al., 1998) were cultured in
DME and 10% donor calf serum. 2.5  g/ml puromycin was added to the
medium of J2-puro cells. MDCK cells and retroviral packaging cells were
cultured in DME and 10% FCS.
Retroviral vectors
To generate  vpBabe puro, human  v cDNA (provided by J. Loftus,
Scripps Research Institute, La Jolla, CA) was blunted and inserted into
SnabI cut, shrimp alkaline phosphatase–treated pBabe puro vector (Levy et
al., 1998) using T4 ligase.  4pBabe puro and  6pBabe puro were gifts
from J. Marshall and I. Hart (Cancer Research UK, London, UK; Thomas et
al., 2001b). M
 Akt:ER* and A2M
 Akt:ER (Kohn et al., 1998; Mirza et al.,
2000) in retroviral vector pWZLneo were gifts of L.M. Martins and J.
Downward (Cancer Research UK, London, UK). eGFP-dNFADD-AU1 was
excised from pcDNA3-AU1-NF4D (a gift of J. Downward; Rytömaa et al.,
1999) with NheI and BamHI, blunted and inserted into SnabI cut, shrimp
alkaline phosphatase–treated pBabe puro using T4 ligase.
The chimeric  6/ 5 integrin subunit ( X6C5) was constructed as follows.
The  6 extracellular and transmembrane domain was made by PCR using
 6pBabe puro as a template. The primers used had the BamHI and EcoRI
sites added and were as follows: 5 -GGGATCCGCCACCATGGGGAT-
TGAACTGCTTTGCCTGTTCTT-3 ; 3 -GGAATTCTTCCAGATGCACAGTA-
GGACAACCCCGATGA. The resulting  6 cytoplasmic domain-deleted PCR
product ( 6 C) was cloned into pCR-4-TOPO, cut with EcoRI and BamHI,
and ligated into pBabe puro. The cytoplasmic domain of  5 was purchased
as part of an I.M.A.G.E. clone (7160-k21; Geneservice) and generated by
PCR using primers that had an EcoRI site at the 5  prime end and SalI at the
3  end. The primers were as follows: 5 -GGAATTCTGCTTGTCACCATC-
CACGACCGGAGGGAGTT-3 ; 3 -GAGTCGACTCAGTCCACAGTGCCAT-
TGTAGGATTTGTTG. The confirmed sequence was cut using EcoRI and
SalI and ligated into  6 C pBabe puro giving the  X6C5 chimeric mole-
cule, but with an additional EcoRI site. This site was removed using Mung
Bean Nuclease. The cDNA was then religated, bringing the chimeric inte-
grin subunit correctly into frame.
Retroviral transduction
Ecotropic Phoenix packaging cells were transiently transfected with retro-
viral vectors, and virus-containing supernatants were used to infect AM12
packaging cells, as described previously (Legg et al., 2003). 60–85% of
AM12 cells transduced with retrovirally encoded integrin subunits had
high surface expression of the integrins following puro selection; these
cells were selected by FACS
® to achieve high expression in  95% of the
population (Levy et al., 1998). Stably transduced AM12 cells were cultured
with 2.5  g/ml puromycin or, in the case of the Akt retroviral vectors, 2
mg/ml G418 (Geneticin; GIBCO BRL).
SCC cells and primary keratinocytes were transduced with retroviral
vectors either by coculture with AM12 cells (Levy et al., 1998) or by incu-
bation with AM12 supernatant (Legg et al., 2003). 70–85% of epithelial
cells had high surface expression of the retrovirally encoded integrin sub-
units after puro selection; these cells were further enriched by FACS
® as
described for AM12 cells.
When cells were transduced with two retroviral vectors, selection was
either with puromycin and FACS
® or with puromycin and neomycin. SCC
and primary keratinocytes transduced with retroviral vectors were cultured
with 1  g/ml puromycin and/or 2 mg/ml G418, as appropriate.
Antibodies
The following mAbs to human integrins were used: HAS4 ( 2 1), VM-2
( 3 1), 7.2R ( 4; a gift from J. Marshall and I. Hart), 13C2 ( v subunit),
PIIW7 ( v subunit), P1D6 ( 5 1; Chemicon), GoH3 ( 6 integrins), P1F6
( v 5), AB1932 ( v 3; Chemicon), 23C6 ( v 3), 10D5 ( v 6; Chemi-
con), MPF410 ( 6 integrins), P5D2 ( 1 integrins), and 3E1 ( 4 integrin
subunit). We used JG22 to detect chick  1 integrins. Actin was detected
with AC40 (Sigma-Aldrich), transglutaminase 1 with B.C1 (a gift of R. Rice,
University of California, Davis, Davis, CA), and involucrin with SY5. An
antibody to AU1 was purchased from Covance and anti-p110  PI3K was
purchased from BD Biosciences. Rabbit antibodies were also purchased as
follows: ER (HC20; Santa Cruz Biotechnology, Inc.), serine 473–phosphor-
ylated Akt (Biosource International; Cell Signaling Technology), total Akt
(Cell Signaling Technology), Erk1/2 (Cell Signaling Technology), phospho-
Erk1/2 (Thr202/Tyr204; Cell Signaling Technology), Erk2 (SC-1647; Santa
Cruz Biotechnology, Inc.), and PTEN (Cascade Biologics, Inc.). Rabbit anti-
bodies against  5 and  6 used for Western blotting were purchased from
Calbiochem. Species-specific secondary antibodies conjugated to Alexa
488 or Alexa 594 were purchased from Molecular Probes, and HRP-conju-
gated second antibodies were purchased from Amersham Biosciences.
FACS
®, flow cytometry, and immunofluorescence staining
Live cells were labeled with antibodies diluted in PBSABC and sorted into
FAD, 10% FCS, and HICE medium using a FACSVantage™ machine (Bec-
ton Dickinson), as described previously (Levy et al., 1998). Involucrin and
transglutaminase 1 expression was examined by flow cytometry of PFA-
fixed, saponin-permeabilized cells, as described previously (Gandarillas et
al., 1999), using a FACScan™ machine (Becton Dickinson).430 The Journal of Cell Biology | Volume 166, Number 3, 2004
DNA content of ethanol-fixed cells stained with 5 g/ml propidium io-
dide in the presence of RNase A (50  g/ml) was determined with a FACS-
Calibur flow cytometer.
Focal adhesions were visualized in cells fixed for 10 min with 4% form-
aldehyde in PBS and 0.1% Triton X-100, as described previously (Levy et
al., 2000). Cells were examined at RT with a confocal laser scanning mi-
croscope (model LSM 510; Carl Zeiss MicroImaging, Inc.) and software
(Carl Zeiss MicroImaging, Inc.) using a 40/NA 1.2 objective (Carl Zeiss Mi-
croImaging, Inc.).
Adhesion assays
Vitronectin was purified from human plasma (Cheresh and Spiro, 1987)
and coated onto 96-well bacterial plates (Evans et al., 2003). Cells were la-
beled with 5  M of CellTracker dye (Molecular Probes), harvested with
trypsin/EDTA, and resuspended at 4   10
5 cells/ml in TBS containing 1
mM Mn
2 . 100  l of cell suspension was added per well and incubated at
37 C for 30 min. The number of adherent cells was quantitated as de-
scribed previously (Evans et al., 2003).
Anchorage-independent growth and suspension culture
Anchorage independent growth in soft agar was evaluated as described
previously (Jones et al., 1996). 5   10
3 cells per 35-mm dish in 0.3% agar
were cultured for 3 wk, and then stained with 1 mg/ml of nitroblue tetrazi-
lium dye (Sigma-Aldrich). All colonies  140  m in diameter in each of the
three randomly chosen 0.8-cm
2 fields were scored under a dissecting
microscope.
Cells were suspended in medium supplemented with 3.5 g/200 ml of
methyl cellulose (Sigma-Aldrich), essentially as described previously (Levy
et al., 2000), except that the concentration of HICE cocktail was one tenth
that in the normal culture medium. The following inhibitors were used at
the concentrations indicated: z-VAD-fmk (100 M; ICN Biomedicals),
z-LIEH-fmk (100 M; Sigma-Aldrich), z-LEHD-fmk (100 M; Sigma-
Aldrich), LY294002 (50  M; Sigma-Aldrich), SB203580 (10  M; Sigma-
Aldrich), and U0126 (10  M; Promega).
Western blotting
Cells were lysed on ice in a modified RIPA buffer containing 50 mM Tris,
pH 8.0, 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% deoxycholate, 5 mM
EDTA, and 1% Triton X-100, with protease and phosphatase inhibitor
cocktails (Sigma-Aldrich; Hobbs and Watt, 2003). Soluble proteins were
resolved by SDS-PAGE on 10% Laemmli gels and transferred onto Immo-
bilon PVDF membranes (Millipore). Antibody labeling was performed as
described previously using a chemiluminescence kit (Western Lightning;
NEN Life Science Products) for detection (Hobbs and Watt, 2003).
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